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The health benefits associated with regular consumption of n-3 polyunsaturated 
fatty acids (PUFA) are well established, mainly due to the presence of 
docosahexaenoic (DHA, 22:6n-3) and eicosapentaenoic (EPA, 20:5n-3) fatty 
acids in diet. In the past few decades, beneficial associations have been made 
with the consumption of microalgae as a new and potential source of n-3 PUFA 
in diet. Microalgae, are sea producers of long chain fatty acids and appear very 
attractive as new dietary sources of PUFAs. This study attempted to evaluate the 
effect of daily supplementation with the microalga Diacronema vlkianum in 
rodents. Fourteen/15 male Wistar rats/group respectively were orally 
administered, by gavage, with 0 (control) or 100mg/Kg/day of microalgae 
suspended in water. The behaviour of the animals was monitored daily. 
Animals were sacrificed after 15 and 60 days of supplementation. Tissues (heart, 
liver, brain, and kidney) were collected, preserved at -80ºC, for subsequent fatty 
acid profiling by GC-FID. The total blood was also collected and washed red 
blood cells (RBC) membranes were obtained. Statistical analysis of obtained 
data consisted of two-sample assuming unequal variances t-student’s. 
Comparisons were made between microalgae-supplemented and control groups, 
at the selected sacrifice time points. Differences were considered significant at 
p<0.05.  
D. vlkianum main n-3 PUFA were 20:5n-3 (EPA), 22:5n-3 (DPA) and 22:6n-3 
(DHA) used as biomarkers of tissue incorporation of microalgae components. 
The RBC used as good indicator of lipid incorporation after long term  diets 
showed a higher percentage of EPA and DPA in treated rats 1.32% ± 0.11 and 
2.32% ±0.10 compared with controls 0.59%±0.07 and 1.65%±0.16, respectively. 
Besides, the values for the total n-3 fatty acids in RBC had a significant 
difference in treated rats (10.40% ± 0.25) face to controls (9.05%±0.28). In 
cardiac tissue, results showed a positive increase of EPA with significant 
differences in treated rats (0.43%± 0.01) contrasting to controls (0.16%±0.09). In 
the liver tissue significant differences among the two different groups, for the fatty 
acids EPA and DPA were observed. Therefore, EPA in treated rats had a 
percentage of 2.11% ±0.19 comparing to smaller value in controls 0.93%±0.14. 
DPA ranged from 2.05%± 0.25 in treated rats and 1.17%± 0.28 in controls. In 
brain and kidney tissue no significant differences were observed between the two 
groups. 
The increase of EPA and DPA in the animals’ tissues suggests a promising 
dietary use of microalga D. vlkianum.  
 
 
